FNBT
SLXP

FineMark National Bank & Trust’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

FineMark National Bank & Trust’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-781
Closed -$122K – 1476
2014
Q3 		$122K Buy
781
+138
+21% +$20K 0.02% 429
2014
Q2 		$80K Buy
643
+198
+44% +$21.9K 0.01% 519
2014
Q1 		$46K Sell
445
-193
-30% -$19.8K 0.01% 638
2013
Q4 		$58K Hold
638
– – 0.01% 546
2013
Q3 		$42K Buy
638
+437
+217% +$30.1K 0.01% 610
2013
Q2 		$13K Buy
+201
New +$11.5K ﹤0.01% 906

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FineMark National Bank & Trust's SLXP Position: Q4 2014 in Review

FineMark National Bank & Trust sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 781 shares — an estimated $122K sold.

FineMark National Bank & Trust first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $122K in Q3 2014. 346 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • FineMark National Bank & Trust reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
  • FineMark National Bank & Trust sold 781 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $122K.
  • FineMark National Bank & Trust first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 6 quarters.
  • FineMark National Bank & Trust's SALIX PHARMACEUTICALS LTD DEL position peaked at $122K in Q3 2014.
  • 346 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on FineMark National Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.